Dr Kishor Mazumder
M.Pharm, MPH, PhD (Osaka, Japan), Postdoc (Australia), JSPS Fellow(Japan)
I am a pharmacist and adjunct faculty at the School of Optometry and Vision Science (SOVS). I obtained my PhD degree at Osaka University, Japan and was an endeavour postdoctoral fellow at school of biomedical sciences, CSU, Australia. I have been working at Jashore University of Science and Technology as an Associate Professor for the last six years.
PREVIOUS POSITIONS
Dec 2016 – Dec 2021 Sr. Adjunct Lecturer, School of Biomedical Science, Charles Sturt University, Wagga Wagga, Lock back NSW, Australia
Feb 2018 - Feb 2020 Dean, Faculty of Biological Sciences, Jashore University of Science and Technology, Jashore-7408, Bangladesh
Feb 2018 – Jan 2019 Advisor, Research Cell, Jashore University of Science and Technology, Jashore-7408, Bangladesh
May 2018 – Nov 2018 Director, Institutional Quality Assurance Cell (IQAC), USTC
Jan 2018 – Nov 2018 Executive Editor, University of Science and Technology Annual
April 2012 – Dec 2017 Assistant Executive Editor, USTA (Official Journal of USTC)
Mar 2012 – Oct 2017 Associate Professor, Department of Pharmacy, University of Science & Technology Chittagong, Chittagong-4202, Bangladesh
April 2016 – Oct 2016 Research Associate Professor, School of Biomedical Science, Charles Sturt University, Wagga Wagga, Lock back NSW, Australia
Dec 2015 – June 2016 Additional Director, IQAC, USTC
Sep 2015 – April 2016 Assistant Controller of Examinations, USTC
Jan 2008 – Feb 2012 Assistant Professor, Department of Pharmacy, University of Science & Technology Chittagong, Chittagong-4202, Bangladesh
Sep 2003 – Jan 2008 Lecturer, Department of Pharmacy, University of Science & Technology Chittagong, Chittagong-4202, Bangladesh
Jun 2003 - Aug 2003 Product Executive, Product Management Department, Somatech
Pharmaceuticals Ltd. 9/A Dhanmandi R/A, Dhaka, Bangladesh
- Publications
- Media
- Grants
- Awards
- Research Activities
- Engagement
- Teaching and Supervision
Sl. No. |
Title |
Allocation (USD) |
Duration |
Source |
Status |
Role |
1. |
Design and evaluation of controlled release micropellets of risperidone for oral delivery using QbD approach |
5,000 |
2 years |
JUST Research Cell |
Completed |
Principal investigator |
2. |
Biopharmaceutic profiling of pH responsive and jejunum specific oral delivery of insulin loaded nanoparticles using different types of enzyme inhibitors and penetration enhancers
|
3,650
|
1 year
|
Ministry of Science and Technology, GoB
|
Completed
|
Principal investigator |
4. |
Study on the improvement and mechanism of natural products, amoradicin on rheumatoid arthritis in mice model.
|
5,000
|
1 year
|
Innoscience, Malaysia
|
Completed
|
Principal investigator |
5. |
Evaluation of bio-distribution, pharmacodynamics, pharmacokinetics and efficacy of newly formulated nanoparticle based oral insulin delivery system using rat models
|
3,750
|
1 year
|
Ministry of Science and Technology, GoB
|
Completed
|
Principal investigator |
6. |
Method Development and Validation for Cost Effective Isolation and Purification of Cysteine from Biological Wastes
|
3,750
|
1 year |
UGC, Bangladesh
|
|
Principal investigator |
7. |
“Design and development of methacrylic acid and methylacrylate copolymer-based insulin loaded nanoparticles for pH sensitive jejunum specific delivery” under consideration for Grant of Advanced Research in Education (GARE) supported by Ministry of Education, Government of the People’s Republic of Bangladesh. |
28,750
|
July 2016 to June 2019
|
Grant of Advanced Research in Education (GARE) supported by Ministry of Education, Government of the People’s Republic of Bangladesh.
|
Completed
|
Principal investigator |
8.
|
Investigation of functional and biofunctional properties of Lupins. A joint project between FGC, Charles Sturt University and Department of Pharmacy, USTC
|
4,000/year
|
March 2017 to 2019
|
Graham Center, Charles Sturt University, wagga, NSW, Australia
|
Completed
|
Principal investigator |
9. |
Targeting Betulin and Ellagic acid as an potential anticancer candidate from Bangladeshi medicinal plant: Phyllanthus watsonii, ID-247, Medical Science Group serial no: 31 |
2,500
|
July 2015 to June 2016
|
Ministry of Sci. & Tech., GoB
|
Completed
|
Principal investigator |
10. |
Evaluation of Ethnic and Heritable differences of Diabetes causing GLUT-2 (SLC2A2) gene and identification of Pharmacogenomic response in Bangladeshi peoples. |
4,000 |
July 2021 to June 2022 |
UGC-JUST |
Completed |
Principal investigator |
11. |
Exploring the immunomodulatory potential of Bangladeshi medicinal plants; identification of active ingredients and their derivatization by biomimetic oxidation system
|
|
April 2020 to March 2023 |
UGC-JSPS joint research |
Ongoing |
Principal investigator |
Endeavour Postdoctoral Research Fellowship from Australian Government
1st prize in the oral presentation in IAPST Conference 2014, Kolkata, India
G- COE Fellowship from Japanese Government
BMC Fellowship, Osaka University, Japan.
JGC-S Scholarship, JCGC-S Foundation Japan.
Nanoparticle based site and target specific drug delivery (Especially, ocular drug delivery through contact lenses) by using different biocompatible and biodegradable polymers and metals.
Exploring immunomodulators form Bangladesh medicinal plants against viral infections such as SARC-CoV-2.
Isolation and characterization of bio-active compounds from Functional Grains, medicinal plants, microbes, marine organism and animals.
Application of modern techniques such as NMR, LC-MS to structural elucidation of organic molecules.
Biological and Pharmacological screening of Plant extracts and bio-active novel compounds and tracking the underlining mechanism of actions.
Derivatization of bioactive compounds by using Ru-porphyrin based biomemetic catalyst with a aim of lead discovery and optimization.